Literature DB >> 16989760

The treatment of congenital dacryocystocele.

Bruce B Becker1.   

Abstract

PURPOSE: To determine the proper management of congenital dacryocystocele.
DESIGN: Retrospective interventional case series. SETTINGS: Clinical practice. STUDY POPULATION: Twenty-seven consecutive patients with 29 congenital dacryocystoceles who presented from 1987 through 2006. MAIN OUTCOME MEASURES: The charts were reviewed for the presence and age of onset of infection, methods and age of treatment, and response to treatment.
RESULTS: Dacryocystitis and preseptal cellulitis requiring intravenous antibiotic therapy were present in 11 lacrimal systems (37.9%), and dacryocystitis without cellulitis was present in an additional 10 lacrimal systems (34.5%). One or more probings were performed in 26 patients (89.7%). Resolution with conservative therapy occurred in three lacrimal systems. The initial probing was successful in seven of seven lacrimal systems (100%) that did not have infection, but was successful in only 10 of 19 lacrimal systems (53%) that had dacryocystitis with or without cellulitis. The mean age of probing in the surgical patients who did not develop infection was 5.9 days, whereas the mean age at first probing in surgical patients who developed infection was 17.3 days.
CONCLUSIONS: Patients with congenital dacryocystocele should have probing on an urgent basis and as early in life as possible, unless the lacrimal sac decompresses into the nose at the time of the initial examination. This approach will reduce the incidence of dacryocystitis and cellulitis, and improve the success rate of surgery.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16989760     DOI: 10.1016/j.ajo.2006.05.043

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  16 in total

1.  A rare cause of upper airway obstruction in neonates.

Authors:  Rana Alia; Irfan Jeeva; Lawrence Miall; Vernon Long
Journal:  BMJ Case Rep       Date:  2012-07-09

2.  A case of congenital dacryocystocele.

Authors:  You Jin Ha; Hae Young Choi; Ki Bum Myung; You Won Choi
Journal:  Ann Dermatol       Date:  2010-02-28       Impact factor: 1.444

3.  Prevalence and clinical characteristics of congenital dacryocystocele.

Authors:  Julia Shekunov; Gregory J Griepentrog; Nancy N Diehl; Brian G Mohney
Journal:  J AAPOS       Date:  2010-10       Impact factor: 1.220

4.  Congenital dacryocystocele: diagnosis and treatment.

Authors:  S Cavazza; G L Laffi; L Lodi; G Tassinari; D Dall'Olio
Journal:  Acta Otorhinolaryngol Ital       Date:  2008-12       Impact factor: 2.124

5.  The association of neonatal dacryocystoceles and infantile dacryocystitis with nasolacrimal duct cysts (an American Ophthalmological Society thesis).

Authors:  Gregg T Lueder
Journal:  Trans Am Ophthalmol Soc       Date:  2012-12

6.  The presentation, clinical features, complications, and treatment of congenital dacryocystocele.

Authors:  R Davies; W J Watkins; S Kotecha; P Watts
Journal:  Eye (Lond)       Date:  2017-10-27       Impact factor: 3.775

7.  Clinical Outcome of Probing in Infants with Acute Dacryocystitis - A Prospective Study.

Authors:  Bhawesh Chandra Saha; Rashmi Kumari; Bibhuti Prasanna Sinha
Journal:  J Clin Diagn Res       Date:  2017-08-01

8.  Process of spontaneous resolution in the conservative management of congenital dacryocystocele.

Authors:  Masashi Mimura; Mari Ueki; Hidehiro Oku; Bunpei Sato; Tsunehiko Ikeda
Journal:  Clin Ophthalmol       Date:  2014-02-26

9.  Congenital nasolacrimal duct cyst/dacryocystocele: An argument for a genetic basis.

Authors:  Henry P Barham; Justin M Wudel; Robert W Enzenauer; Kenny H Chan
Journal:  Allergy Rhinol (Providence)       Date:  2012-05-03

10.  Outcomes of lacrimal probing surgery as the first option in the treatment of congenital dacryocystocele.

Authors:  Cetin Akpolat; Selam Yekta Sendul; Ebru Turkoglu Unal; Egemen Karatas; Cemile Ucgul Atilgan; Mehmet Demir
Journal:  Ther Adv Ophthalmol       Date:  2021-07-09
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.